COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 846: Articles 8451-8460  | Next

SARS-CoV-2 Delta breakthrough infections in vaccinated patients
Zou, J., Xie, X., Liu, M., Shi, P.-Y., Ren, P.
10.1101/2022.04.12.488092 — Posted: 2022-04-13
Broadly neutralizing and protective nanobodies against diverse sarbecoviruses
Li, M., Ren, Y., Aw, Z. Q., Chen, B., Yang, Z., Lei, Y., Cheng, L., Liang, Q., Hong, J., Yang, Y., Chen, J., Wong, Y. H., Shan, S., Zhang, S., Ge, J., Wang, R., Shi, X., Zhang, Q., Zhang, Z., Chu, J. J. H., Wang, X., Zhang, L.
10.1101/2022.04.12.488087 — Posted: 2022-04-13
Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: A multiprovincial test-negative design study
Nasreen, S., Febriani, Y., Garcia, H. A. V., Zhang, G., Tadrous, M., Buchan, S. A., Righolt, C., Mahmud, S. M., Janjua, N. Z., Krajden, M., Serres, G. D., Kwong, J. Z.
10.1101/2022.04.13.22273825 — Posted: 2022-04-13
Multiplex RT-qPCR assay (N200) to detect and estimate prevalence of multiple SARS-CoV-2 Variants of Concern in wastewater
Fuzzen, M. L. M., Harper, N. B., Dhiyebi, H. A., Srikanthan, N., Hayat, S., Peterson, S. W., Yang, I., Sun, J. X., Edwards, E. A., Giesy, J. P., Mangat, C. S., Graber, T. E., Delatolla, R. E., Servos, M. R.
10.1101/2022.04.12.22273761 — Posted: 2022-04-13
Nowcasting and Forecasting COVID-19 Waves: The Recursive and Stochastic Nature of Transmission
Albani, V. V. L., Albani, R. A. S., Massad, E., Zubelli, J. P.
10.1101/2022.04.12.22273804 — Posted: 2022-04-13
Health behaviours the month prior to COVID-19 infection and the development of self-reported long COVID and specific long COVID symptoms: A longitudinal analysis of 1,811 UK adults
Paul, E., Fancourt, D.
10.1101/2022.04.12.22273792 — Posted: 2022-04-13
Slight increase in fomite route transmission risk of SARS-CoV-2 Omicron variant compared with the ancestral strain in households
Ji, S., Xiao, S., Wang, H., Lei, H.
10.1101/2022.04.13.22273821 — Posted: 2022-04-13
Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19
Sperry, M. M., Oskotsky, T., Mari_, I., Kaushal, S., Takeda, T., Horvath, V., Powers, R. K., Rodas, M., Furlong, B., Soong, M., Prabhala, P., Goyal, G., Carlson, K. E., Wong, R. J., Kosti, I., Le, B., Logue, J., Hammond, H., Frieman, M., Stevenson, D. K., Ingber, D. E., Sirota, M., Novak, R.
10.1101/2022.04.12.22273802 — Posted: 2022-04-13
Health Economic Burden of COVID-19 in Saudi Arabia
Alenzi, K. A., Al-malky, H. S., Altebainawi, A. A., Abushomi, H. Q., Alatawi, F. O., Atwadi, M. H., Khobrani, M. A., Almazrou, D. A., Alrubeh, N., Alsoliabi, Z. A., Kardam, A. M., Alghamdi, S. A., Alasiri, A., Alshammari, T. M.
10.1101/2022.04.08.22273439 — Posted: 2022-04-13
Protection conferred by vaccine plus previous infection (hybrid immunity) with vaccines of three different platforms during the Omicron variant period in Brazil
Cerqueira-Silva, T., de Araujo Oliveira, V., Paixao, E. S., Florentino, P., Penna, G. O., Pearce, N., Werneck, G. L., Barreto, M. L., Boaventura, V. S., Barral-Netto, M.
10.1101/2022.04.12.22273752 — Posted: 2022-04-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).